Monilola Olayioye graduated from Technical University Braunschweig in biotechnology in 1996, after completing her diploma thesis at the Scripps Research Institute in San Diego. Her PhD studies at the Friedrich Miescher Institute in Basel (1997-2000) on growth factor receptors were followed by postdoctoral work as an Embo fellow in breast cancer research at the Walter and Eliza Hall Institute of Medical Research in Melbourne (2000-2003). In 2005, supported by DFG and DKH start-up grants, she established an independent research group at the Institute of Cell Biology and Immunology at the University of Stuttgart. In 2010, Monilola Olayioye was nominated for a DFG Heisenberg professorship in Molecular Tumor Cell Biology and holds this tenured position since 2011 at the University of Stuttgart. She furthermore heads Biomedical Systems, defined as an emerging research field at the University of Stuttgart, and is member of the Research Council of the University. Monilola Olayioye’s current research focus is on the interplay of oncogenic and tumor suppressive signaling networks in cellular transformation and metastasis formation, and aims at identifying new therapeutic anti-cancer strategies.